Advertisement

Topics

"Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children" Drugs and Medication Database: Page 5

09:00 EDT 25th March 2019 | BioPortfolio

Here are the most relevant "Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children" Drugs and Medications that we have found in our database.

More Information about "Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children" on BioPortfolio

We have published hundreds of Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children news stories on BioPortfolio along with dozens of Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children Clinical Trials and PubMed Articles about Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children Companies in our database. You can also find out about relevant Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children Drugs and Medications on this site too.

Showing "Rapid Evaluation Pandemic H1N1 Influenza Vaccines Young Children" Drugs and Medications 101–116 of 116

Possibly Relevant

Oseltamavir phosphate [remedyrepack inc.]

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OSELTAMIVIR PHOSPHATE CAPSULES safely and effectively. See full prescribing information for OSELTAMIVIR PHOSPHATE CAPSULES. OSELTAMIVIR PHOSPHATE capsu

Oseltamavir phosphate [preferred pharmaceuticals inc.]

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OSELTAMIVIR PHOSPHATE CAPSULES safely and effectively. See full prescribing information for OSELTAMIVIR PHOSPHATE CAPSULES. OSELTAMIVIR PHOSPHATE capsu

Oseltamivir phosphate [northstar rxllc]

These highlights do not include all the information needed to use OSELTAMIVIR PHOSPHATE CAPSULES safely and effectively. See full prescribing information for OSELTAMIVIR PHOSPHATE CAPSULES. OSELTAMIVIR PHOSPHATE capsules, for oral use Initial U.S. Approva

Oseltamivir phosphate [camber pharmaceuticals, inc.]

These highlights do not include all the information needed to use OSELTAMIVIR PHOSPHATE CAPSULES safely and effectively. See full prescribing information for OSELTAMIVIR PHOSPHATE CAPSULES.  OSELTAMIVIR PHOSPHATE capsules, for oral use  Initial U.S. App

Amantadine hydrochloride [actavis pharma, inc.]

Amantadine Hydrochloride Tablets Rx Only

Nitrogen [young welding supply, inc]

Nitrogen

Simponi [janssen biotech, inc.]

These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) injection, for subcutaneous useInitial U.S. Approval: 2009

Engerix-b [dispensing solutions inc.]

ENGERIX-B Hepatitis B Vaccine (Recombinant)

Diphenhydramine hydrochloride [general injectables and vaccines]

Diphenhydramine Hydrochloride 50mg/ml 1ml

Ocrevus [genentech, inc.]

These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS (ocrelizumab) injection, for intravenous use Initial U.S. Approval: 2017

Osmolex er [vertical pharmaceuticals, llc]

These highlights do not include all the information needed to use OSMOLEX ER safely and effectively. See full prescribing information for OSMOLEX ER. OSMOLEX ER (amantadine) extended-release tablets, for oral use  Initial U.S. Approval: 1966

Simponi aria [janssen biotech, inc.]

These highlights do not include all the information needed to use SIMPONI ARIA safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA (golimumab) injection, for intravenous use Initial U.S. Approval: 2009

Lisinopril [state of florida doh central pharmacy]

NA

Ilumya [sun pharma global fze]

These highlights do not include all the information needed to use ILUMYA safely and effectively. See full prescribing information for ILUMYA. ILUMYA™ (tildrakizumab-asmn) injection, for subcutaneous use Initial U.S. Approval: 2018

Soliris [alexion pharmaceuticals inc.]

These highlights do not include all the information needed to use SOLIRIS safely and effectively. See full prescribing information for SOLIRIS. SOLIRIS (eculizumab) injection, for intravenous use Initial U.S. Approval: 2007

Zevalin [spectrum pharmaceuticals, inc.]

These highlights do not include all the information needed to use ZEVALIN safely and effectively. See full prescribing information for ZEVALIN. ZEVALIN® (ibritumomab tiuxetan) injection, for intravenous useInitial U.S. Approval: 2002



Advertisement
Quick Search
Advertisement
Advertisement